Table 1.
Symptomatic COVID-19 infection in the Stockholm HD population, March 12 to April 17, 2020
| Variables | Hospitalized non-survivors | Hospitalized survivors | Outpatient |
|---|---|---|---|
| Patients, n (%) | 9 (22.5) | 15 (37.5) | 16 (40) |
| Male, n (%) | 8 (89) | 13 (87) | 10 (63) |
| Median age, yr (range) | 78 (62–96) | 68 (57–85) | 55.5 (19–86) |
| Age ≥70, n (%) | 8 (89) | 7 (47) | 4 (25) |
| Median dialysis vintage, yr (range) | 11.5 (6–17 y) | 1.5 (1 mo–19 y) | 3 (1 mo–12 y) |
| Oxygen dependent, n (%) | 9 (l00) | 9 (60) | 0 (0) |
| ICU, n (%) | 1 (11) | 0 (0) | na |
| Diabetes mellitus, n (%) | 5 (56) | 8 (53) | 9 (56) |
| BMI >30 kg/m2, n (%) | 0 (0) | 2 (13) | 1 (6) |
| RAAS-blockade, n (%) | 2 (22) | 6 (40) | 9 (56) |
| Immunosuppressive therapy, n (%) | 0 (0) | 1 (6.7) | 4 (25) |
Patients n = 40. HD, hemodialysis; ICU, intensive care unit.